135 related articles for article (PubMed ID: 7127338)
1. Etoposide and etoposide-ifosfamide therapy for refractory testicular tumors.
Bremer K; Niederle N; Krischke W; Higi M; Scheulen ME; Schmidt CG; Seeber S
Cancer Treat Rev; 1982 Jun; 9 Suppl():79-84. PubMed ID: 7127338
[No Abstract] [Full Text] [Related]
2. Etoposide and ifosfamide in combination for inoperable carcinoma of the bronchus.
Schilcher RB; Seeber S; Scheulen ME; Schmidt CG
Cancer Treat Rev; 1982 Jun; 9 Suppl():107-10. PubMed ID: 7127333
[No Abstract] [Full Text] [Related]
3. Etoposide salvage therapy for refractory germ cell tumors: an update.
Williams SD; Einhorn LH
Cancer Treat Rev; 1982 Jun; 9 Suppl():67-71. PubMed ID: 6290056
[No Abstract] [Full Text] [Related]
4. Etoposide for therapy-resistant testicular tumors.
Varini M; Cavalli F
Cancer Treat Rev; 1982 Jun; 9 Suppl():73-8. PubMed ID: 7127337
[No Abstract] [Full Text] [Related]
5. Ifosfamide and etoposide as salvage therapy for non-Hodgkin's lymphoma.
Hagberg H; Cavallin-Ståhl E; Lind J
Scand J Haematol; 1986 Jan; 36(1):61-4. PubMed ID: 3952466
[TBL] [Abstract][Full Text] [Related]
6. Ifosfamide in testicular cancer.
Loehrer PJ
Semin Oncol; 1990 Apr; 17(2 Suppl 4):2-5. PubMed ID: 2159186
[TBL] [Abstract][Full Text] [Related]
7. Does etoposide have curative potential?
Ignoffo RJ
Clin Pharm; 1983; 2(2):167. PubMed ID: 6309470
[No Abstract] [Full Text] [Related]
8. N-acetylcysteine and ifosfamide in the treatment of unresectable pancreatic adenocarcinoma and refractory testicular cancer.
Loehrer PJ; Williams SD; Einhorn LH
Semin Oncol; 1983 Mar; 10(1 Suppl 1):72-5. PubMed ID: 6836331
[No Abstract] [Full Text] [Related]
9. VP16-213 as a single agent in advanced testicular tumors.
Fitzharris BM; Kaye SB; Saverymuttu S; Newlands ES; Barrett A; Peckham MJ; McElwain TJ
Eur J Cancer (1965); 1980 Sep; 16(9):1193-7. PubMed ID: 7227446
[No Abstract] [Full Text] [Related]
10. Ifosfamide in combination chemotherapy for sarcomas and testicular carcinomas.
Niederle N; Scheulen ME; Cremer M; Schütte J; Schmidt CG; Seeber S
Cancer Treat Rev; 1983 Sep; 10 Suppl A():129-35. PubMed ID: 6627239
[TBL] [Abstract][Full Text] [Related]
11. Ifosfamide in the treatment of germ cell tumors.
Nichols CR
Semin Oncol; 1996 Jun; 23(3 Suppl 6):65-73. PubMed ID: 8677452
[TBL] [Abstract][Full Text] [Related]
12. VP-16-213 (etoposide) in the management of germinal testis tumors.
Pizzocaro G
Prog Clin Biol Res; 1985; 203():391-400. PubMed ID: 2421333
[No Abstract] [Full Text] [Related]
13. Combination chemotherapy of small-cell bronchogenic carcinoma with etoposide (VP-16), ifosfamide and vindesine (VPIV), and with adriamycin, cis-platinum and vincristine (APO).
Havemann K
Cancer Treat Rev; 1982 Jun; 9 Suppl():95-100. PubMed ID: 6290059
[No Abstract] [Full Text] [Related]
14. Etoposide (VP 16-213; VePesid).
Med Lett Drugs Ther; 1984 May; 26(661):48-9. PubMed ID: 6325855
[No Abstract] [Full Text] [Related]
15. A phase II study of oral VP-16-213 in non-seminomatous testicular cancer.
Cavalli F; Klepp O; Renard J; Röhrt M; Alberto P
Eur J Cancer (1965); 1981 Feb; 17(2):245-9. PubMed ID: 7262161
[No Abstract] [Full Text] [Related]
16. Phase II trial with etoposide (VP16) plus ifosfamide plus high-dose cisplatin (VIhP regimen) in refractory germ cell tumors.
Droz JP; Ribrag V; Ghosn M; Guimares J; Theodore C; Azab M; Ostronoff M; Mahjoubi M; Moran A; Pico J
Prog Clin Biol Res; 1989; 303():739-47. PubMed ID: 2550949
[No Abstract] [Full Text] [Related]
17. Etoposide: a new anti-cancer agent.
Arnold AM; Whitehouse JM
Lancet; 1981 Oct; 2(8252):912-5. PubMed ID: 6117692
[No Abstract] [Full Text] [Related]
18. VP16-213, cisplatinum, and adriamycin salvage therapy of refractory and/or recurrent nonseminomatous germ cell neoplasms.
Mortimer J; Bukowski RM; Montie J; Hewlett JS; Livingston RB
Cancer Chemother Pharmacol; 1982; 7(2-3):215-8. PubMed ID: 6282486
[TBL] [Abstract][Full Text] [Related]
19. High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group.
Siegert W; Beyer J; Strohscheer I; Baurmann H; Oettle H; Zingsem J; Zimmermann R; Bokemeyer C; Schmoll HJ; Huhn D
J Clin Oncol; 1994 Jun; 12(6):1223-31. PubMed ID: 7911158
[TBL] [Abstract][Full Text] [Related]
20. Ifosfamide: European perspective.
Burkert H
Semin Oncol; 1982 Dec; 9(4 Suppl 1):28-35. PubMed ID: 6761866
[No Abstract] [Full Text] [Related]
[Next] [New Search]
